IRF3 and hepatocellular carcinoma: The fourth variant, IRF3e or IRF3-nirs, was discovered when Marozin and colleagues searched for the reason of the defect in IFNB1 expression in hepatocellular carcinoma (HCC) cells and discovered that a truncated variant of IRF3 was constitutively expressed in primary cells of HCC or HCC cell lines but not in primary hepatocytes [173].